Two classes of medications have drastically changed the way healthcare providers treat type 2 diabetes, and these medicines have tremendous advantages beyond blood sugar control.
read more →
With recent news about SGLT2s and GLP-1 RAs helping to protect against heart disease in addition to their primary purpose of lowering blood sugars, Dr. Edelman addresses the question of whether it’s safe to take them together, and if they can also cause hypoglycemia.
read more →
With newer medication options available now for treating type 2 diabetes, Dr. Edelman answers a common question about how they can be included in a diabetes management regimen with regard to metformin.
read more →
Trijardy is the first triple combo pill for people with type 2 diabetes that combines three meds in one. It helps reduce blood sugar, promote weight loss, improve blood pressure and reduce the risk of coronary artery disease, renal disease and strokes.
read more →
Jeremy Pettus explains the pros and cons of SGLT2s for people with type 1, and offers advice on how to try them safely and smartly.
read more →
SGLT2s are currently only approved for use in the U.S. for type 2 diabetes, but a lot of people with type 1 are taking them off label with positive results.
read more →
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →
